Skip to main content

ESTUDIO DEL EJE INTESTINO-CORAZON: ASOCIACION ENTRE LA INFLAMACION CARDIOVASCULAR Y LOS CAMBIOS DEL SISTEMA INMUNE INDUCIDOS POR EL VIH

PI19/00019

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO HOSPITAL DEL MAR DE INVESTIGACIONES MEDICAS (FIMIM)
Execution centre INSTITUTO HOSPITAL DEL MAR DE INVESTIGACIONES MEDICAS (IMIM)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection

  • Vogel-González, Marina
  • Herrera-Fernández, Víctor
  • Pérez-Vilaró, Gemma
  • Chillon Rodriguez, Miguel
  • Nogués, Xavier
  • Talló-Parra, Marc
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Resultats clínics; Zinc, Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Resultados clínicos; Zinc, Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Clinical outcomes; Zinc, Background: Zinc is an essential micronutrient that impacts host–pathogen interplay at infection. Zinc balances immune responses, and also has a proven direct antiviral action against some viruses. Importantly, zinc deficiency (ZD) is a common condition in elderly and individuals with chronic diseases, two groups with an increased risk for severe severe coronavirus disease 2019 (COVID-19) outcomes. We hypothesize that serum zinc content (SZC) influences COVID-19 disease progression, and thus might represent a useful biomarker. Methods: We ran an observational cohort study with 249 COVID-19 patients admitted in Hospital del Mar. We have studied COVID-19 severity and progression attending to SZC at admission. In parallel, we have studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) replication in the Vero E6 cell line modifying zinc concentrations. Findings: Our study demonstrates a correlation between serum zinc levels and COVID-19 outcome. Serum zinc levels lower than 50 µg/dL at admission correlated with worse clinical presentation, longer time to reach stability, and higher mortality. Our in vitro results indicate that low zinc levels favor viral expansion in SARS-CoV-2 infected cells. Interpretation: Low SZC is a risk factor that determines COVID-19 outcome. We encourage performing randomized clinical trials to study zinc supplementation as potential prophylaxis and treatment with people at risk of zinc deficiency., This work was supported by the Spanish Ministry of Science and Innovation, through grants PID2019-106755RB-I00/AEI/10.13039/501100011033 to R.V. and PID2019-106959RB-I00/AEI/10.13039/501100011033 to J.D.; an institutional “Maria de Maeztu” Programme for Units of Excellence in R&D (CEX2018-000792-M) to R.V. and J.D.; and by the 2017 SGR 909 grant from the Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement of the Generalitat de Catalunya to J.D. R.G.-F. received support and funding from Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES) (grant number CB16/10/00245), FEDER funds, and the FIS Project from Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación (grant number (PI19/00019)).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection

  • Vogel-González, Marina
  • Talló-Parra, Marc
  • Herrera-Fernández, Víctor
  • Pérez-Vilaró, Gemma
  • Chillón Rodríguez, Miguel|||0000-0003-0840-2111
  • Nogués Solán, Xavier|||0000-0002-5537-1859
  • Gómez-Zorrilla, Silvia|||0000-0002-5987-068X
  • López Montesinos, Inmaculada|||0000-0002-2675-4412
  • Arnau-Barrés, Isabel
  • Sorlí, Luisa|||0000-0001-9562-514X
  • Horcajada, Juan Pablo|||0000-0001-9873-5459
  • Garcia-Giralt, Natalia|||0000-0001-6507-0147
  • Pascual, Julio|||0000-0002-4735-7838
  • Díez, Juana|||0000-0002-9013-0751
  • Vicente, Rubén|||0000-0003-0401-4808
  • Güerri-Fernández, Robert|||0000-0002-9794-9161
Background: Zinc is an essential micronutrient that impacts host-pathogen interplay at infection. Zinc balances immune responses, and also has a proven direct antiviral action against some viruses. Importantly, zinc deficiency (ZD) is a common condition in elderly and individuals with chronic diseases, two groups with an increased risk for severe severe coronavirus disease 2019 (COVID-19) outcomes. We hypothesize that serum zinc content (SZC) influences COVID-19 disease progression, and thus might represent a useful biomarker. Methods: We ran an observational cohort study with 249 COVID-19 patients admitted in Hospital del Mar. We have studied COVID-19 severity and progression attending to SZC at admission. In parallel, we have studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) replication in the Vero E6 cell line modifying zinc concentrations. Findings: Our study demonstrates a correlation between serum zinc levels and COVID-19 outcome. Serum zinc levels lower than 50 µg/dL at admission correlated with worse clinical presentation, longer time to reach stability, and higher mortality. Our in vitro results indicate that low zinc levels favor viral expansion in SARS-CoV-2 infected cells. Interpretation: Low SZC is a risk factor that determines COVID-19 outcome. We encourage performing randomized clinical trials to study zinc supplementation as potential prophylaxis and treatment with people at risk of zinc deficiency.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Severe hypoalbuminemia at admission is strongly associated with worse prognosis in older adults with sars-cov-2 infection

  • Arnau-Barrés, Isabel
  • Pascual-Dapena, Ana
  • López Montesinos, Inmaculada|||0000-0002-2675-4412
  • Gómez-Zorrilla, Silvia|||0000-0002-5987-068X
  • Sorlí, Luisa|||0000-0001-9562-514X
  • Herrero-Torrus, Marta
  • Nogués Solán, Xavier|||0000-0002-5537-1859
  • Navarro-Valls, Claudia
  • Ibarra, Beatriz
  • Canchucaja, Lizzeth
  • Da Costa, Elizabeth
  • Blasco-Hernando, Fabiola
  • Cruz, Juany
  • Vázquez Ibar, Olga|||0000-0001-8260-4585
  • Miralles Basseda, Ramon|||0000-0002-7770-7819
  • Garcia-Giralt, Natalia|||0000-0001-6507-0147
  • Güerri-Fernández, Robert|||0000-0002-9794-9161
Serum albumin levels have been associated with prognosis in several conditions among older adults. The aim of this study is to assess the prognostic value in mortality of serum albumin in older adults with SARS-CoV-2 infection. Methods. Cohort observational study with consecu-tive older-adults (≥65 years old), with confirmed SARS-CoV-2 infection admitted to a university hospital between March-May 2020. A logistic regression model was fitted to assess the impact of albumin levels on in-hospital mortality adjusted by potential confounders. Results. Among a total of 840 patients admitted to the hospital, 405 (48%) were older adults with a total of 92 deaths (23%) among them. Those who died were older, had more comorbidities, higher inflammation status and lower levels of serum albumin at admission [3.10 g/dL (0.51) vs. 3.45 g/dL (0.45); p < 0.01. Serum albumin levels at admission were negatively correlated with inflammatory markers such as C-Reactive protein (Pearson Coeff -0.4634; p < 0.001) or IL-6 (Pearson's Coeff -0.244; p = 0.006) at admission but also to other clinical outcomes such time to clinical stability (Pearson's Coeff -0.259; p < 0.001). Severe hypoalbuminemia associated with increased risk of mortality was defined as ≤3 g/dL at admission according to the AUC/ROC analysis (0.72 95%CI 0.63-0.81) In a multivariate logistic regression model adjusting by age, inflammation, comorbidities and severity at admission severe hypoalbuminemia was a strong predictor of in-hospital mortality (OR 2.18 95% CI 1.03-4.62; p = 0.039). Conclusion. Severe hypoalbuminemia with ≤3 g/dL is an independent risk factor for mortality among older adults with SARS-CoV-2 infection. There is a consistent correlation between albumin levels and inflammatory biomarkers. Further studies are needed to determine whether the supplementation of albumin as coadjuvant treatment will have a positive impact on the prognosis of this infection.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prevalence and prognostic value of myocardial injury in the initial presentation of sars-cov-2 infection among older adults

  • Arnau-Barrés, Isabel
  • Pascual-Dapena, Ana
  • López Montesinos, Inmaculada|||0000-0002-2675-4412
  • Gómez-Zorrilla, Silvia|||0000-0002-5987-068X
  • Sorlí, Luisa|||0000-0001-9562-514X
  • Herrero-Torrus, Marta
  • Nogués Solán, Xavier|||0000-0002-5537-1859
  • Montero, Mila
  • Vázquez Ibar, Olga|||0000-0001-8260-4585
  • Garcia-Giralt, Natalia|||0000-0001-6507-0147
  • Miralles Basseda, Ramon|||0000-0002-7770-7819
  • Güerri-Fernández, Robert|||0000-0002-9794-9161
Myocardial involvement during SARS-CoV-2 infection has been reported in many prior publications. We aim to study the prevalence and the clinical implications of acute myocardial injury (MIN) during SARS-CoV-2 infection, particularly in older patients. The method includes a longitudinal observational study with all consecutive adult patients admitted to a COVID-19 unit between March-April 2020. Those aged ≥65 were considered as older adult group. MIN was defined as at least 1 high-sensitive troponin (hs-TnT) concentration above the 99th percentile upper reference limit with different sex-cutoff. Results. Among the 634 patients admitted during the period of observation, 365 (58%) had evidence of MIN, and, of them, 224 (61%) were older adults. Among older adults, MIN was associated with longer time to recovery compared to those without MIN (13 days (IQR 6-21) versus 9 days (IQR 5-17); p < 0.001, respectively. In-hospital mortality was significantly higher in older adults with MIN at admission versus those without it (71 (31%) versus 11 (12%); p < 0.001). In a logistic regression model adjusting by age, sex, severity, and Charlson Comorbidity Index, the OR for in-hospital mortality was 2.1 (95% CI: 1.02-4.42; p = 0.043) among those older adults with MIN at admission. Older adults with acute myocardial injury had greater time to clinical recovery, as well as higher odds of in-hospital mortality.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Individuals With Higher CD4/CD8 Ratio Exhibit Increased Risk of Acute Respiratory Distress Syndrome and In-Hospital Mortality During Acute SARS-CoV-2 Infection

  • Pascual-Dapena, Ana
  • Chillaron, Juan Jose|||0000-0002-8096-1703
  • Llauradó, Gemma|||0000-0002-3237-6366
  • Arnau-Barrés, Isabel
  • Flores, Juana María
  • Lopez-Montesinos, Inmaculada
  • Sorlí, Luisa|||0000-0001-9562-514X
  • Luis Martínez-Pérez, Juan
  • Gómez-Zorrilla, Silvia|||0000-0002-5987-068X
  • Du, Juan
  • Garcia-Giralt, Natalia|||0000-0001-6507-0147
  • Güerri-Fernández, Robert|||0000-0002-9794-9161
CD4/CD8 ratio has been used as a quantitative prognostic risk factor in patients with viral infections. This study aims to assess the association between in-hospital mortality and at admission CD4/CD8 ratio among individuals with acute SARS-CoV-2 infection. This is a longitudinal cohort study with data of all consecutive patients admitted to the COVID-19 unit at Hospital del Mar, Barcelona, Spain for ≥48 h between March to May 2020. The CD4+ CD8+ T-cell subset differentiation was assessed by flow cytometry at admission as well as a complete blood test. Patients were classified according to CD4/CD8 ratio tertiles. The primary outcome was in-hospital mortality and the secondary outcome was acute respiratory distress (ARDS). A total of 338 patients were included in the cohort. A high CD4/CD8 ratio (third tertile) was associated with a higher in-hospital mortality [adjusted Cox model hazard ratio (HR) 4.68 (95%CI 1.56-14.04, p = 0.006), reference: second tertile HR 1]. Similarly, a high CD4/CD8 ratio (third tertile) was associated with a higher incidence of ARDS [adjusted logistic regression model OR 1.97 (95%CI 1.11-3.55, p = 0.022) reference: second tertile HR 1]. There was a trend of higher in-hospital mortality and incidence of ARDS in patients within the first tertile of CD4/CD8 ratio compared with the second one, but the difference was not significant. No associations were found with total lymphocyte count or inflammatory parameters, including D-dimer. CD4/CD8 ratio is a prognostic factor for the severity of COVID-19, reflecting the negative impact on prognosis of those individuals whose immune response has abnormal CD8+ T-cell expansion during the early response to the infection.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Pan-pox-specific T-cell responses in HIV-1-infected individuals after JYNNEOS vaccination

  • Sisteré-Oró, Marta|||0000-0003-0214-6348
  • Du, Juan
  • Wortmann, Diana D.J.
  • Filippi, Marina D.
  • Cañas-Ruano, Esperanza|||0000-0002-4651-7545
  • Arrieta-Aldea, Itziar
  • Marcos-Blanco, Agustín
  • Castells, Xavier|||0000-0002-2528-0382
  • Grau, Santiago|||0000-0002-8428-1836
  • Garcia-Giralt, Natalia|||0000-0001-6507-0147
  • Perez-Zsolt, Daniel|||0000-0003-4192-7622
  • Boreika, Rytis|||0000-0001-6720-1577
  • Izquierdo Useros, Nuria|||0000-0002-1039-1821
  • Güerri-Fernández, Robert|||0000-0002-9794-9161
  • Meyerhans, Andreas|||0000-0003-0620-5317
People living with human immunodeficiency virus (HIV) are the individuals most affected by the current Monkeypox virus outbreak that was first announced in May 2022. Here we report Pan-pox-specific T-cell responses in a cohort of HIV-1-infected individuals after receiving the nonreplicative, attenuated smallpox vaccine JYNNEOS from Bavarian Nordic. Intradermal (i.d.) and subcutaneous (s.c.) vaccination was safe without major side effects. Dose-sparing i.d. vaccination was superior to s.c. vaccination and promoted T-cell polyfunctionality, and the expression of the gut-homing marker α4β7 integrin on lymphocytes. HIV-1-infected individuals with CD4 T-cell counts ≤500/mm blood required at least a booster vaccination to exhibit efficient virus-specific T-cell responses. The magnitude of the Th1 response after this booster directly correlated with the CD4 T-cell count of the vaccinees. Further studies with a larger number of participants are warranted to confirm and expand our observations.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection

  • Vogel-González, Marina
  • Herrera-Fernández, Víctor
  • Pérez-Vilaró, Gemma
  • Chillon Rodriguez, Miguel
  • Nogués, Xavier
  • Talló-Parra, Marc
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Resultats clínics; Zinc, Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Resultados clínicos; Zinc, Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Clinical outcomes; Zinc, Background: Zinc is an essential micronutrient that impacts host–pathogen interplay at infection. Zinc balances immune responses, and also has a proven direct antiviral action against some viruses. Importantly, zinc deficiency (ZD) is a common condition in elderly and individuals with chronic diseases, two groups with an increased risk for severe severe coronavirus disease 2019 (COVID-19) outcomes. We hypothesize that serum zinc content (SZC) influences COVID-19 disease progression, and thus might represent a useful biomarker. Methods: We ran an observational cohort study with 249 COVID-19 patients admitted in Hospital del Mar. We have studied COVID-19 severity and progression attending to SZC at admission. In parallel, we have studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) replication in the Vero E6 cell line modifying zinc concentrations. Findings: Our study demonstrates a correlation between serum zinc levels and COVID-19 outcome. Serum zinc levels lower than 50 µg/dL at admission correlated with worse clinical presentation, longer time to reach stability, and higher mortality. Our in vitro results indicate that low zinc levels favor viral expansion in SARS-CoV-2 infected cells. Interpretation: Low SZC is a risk factor that determines COVID-19 outcome. We encourage performing randomized clinical trials to study zinc supplementation as potential prophylaxis and treatment with people at risk of zinc deficiency., This work was supported by the Spanish Ministry of Science and Innovation, through grants PID2019-106755RB-I00/AEI/10.13039/501100011033 to R.V. and PID2019-106959RB-I00/AEI/10.13039/501100011033 to J.D.; an institutional “Maria de Maeztu” Programme for Units of Excellence in R&D (CEX2018-000792-M) to R.V. and J.D.; and by the 2017 SGR 909 grant from the Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement of the Generalitat de Catalunya to J.D. R.G.-F. received support and funding from Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES) (grant number CB16/10/00245), FEDER funds, and the FIS Project from Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación (grant number (PI19/00019)).